DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 123 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $119,000 | +101.7% | 9,721 | +99.2% | 0.00% | – |
| Q2 2023 | $59,000 | +59.5% | 4,881 | +74.1% | 0.00% | – |
| Q1 2023 | $37,000 | -60.2% | 2,804 | -35.4% | 0.00% | – |
| Q4 2022 | $93,000 | +210.0% | 4,339 | +187.9% | 0.00% | – |
| Q3 2022 | $30,000 | +36.4% | 1,507 | +18.1% | 0.00% | – |
| Q2 2022 | $22,000 | -12.0% | 1,276 | -49.8% | 0.00% | – |
| Q1 2022 | $25,000 | -54.5% | 2,542 | -23.1% | 0.00% | – |
| Q4 2021 | $55,000 | +66.7% | 3,305 | +140.2% | 0.00% | – |
| Q3 2021 | $33,000 | – | 1,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |